Search

Your search keyword '"Chiang C. E."' showing total 192 results

Search Constraints

Start Over You searched for: Author "Chiang C. E." Remove constraint Author: "Chiang C. E."
192 results on '"Chiang C. E."'

Search Results

1. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

2. Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

6. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

7. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

8. P1226Very low achieved low-density lipoprotein cholesterol level with alirocumab treatment after acute coronary syndrome: ODYSSEY OUTCOMES

10. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

11. Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015

12. Dapagliflozin and cardiovascular outcomes in type 2 diabetes

13. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

14. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

16. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

17. Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015

18. P5554TIMI risk score for secondary prevention of recurrent cardiovascular events in a real world cohort of post acute ST-elevation myocardial infarction patients

19. P1727TIMI risk score for secondary prevention of recurrent cardiovascular events in a real world cohort of post acute non-ST-elevation myocardial infarction patients

20. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

21. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

22. Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48

23. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

27. Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015.

28. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

29. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

36. Accessory atrioventricular pathways with only antegrade conduction in patients with symptomatic Wolff-Parkinson-White syndrome: Clinical features, electrophysiological characteristics and response to radiofrequency catheter ablation

41. Catheter ablation of free wall accessory atrioventricular pathways in 89 patients with Wolff-Parkinson-White Syndrome-comparison of direct current and radiofrequency ablation

Catalog

Books, media, physical & digital resources